Breaking News Instant updates and real-time market news.

MRUS

Merus

$17.91

0.39 (2.23%)

07:03
10/19/16
10/19
07:03
10/19/16
07:03

Merus receives undisclosed milestone payment from Ono Pharmaceutical

Merus announced that the company received an undisclosed milestone payment from Ono Pharmaceutical, under the ongoing collaboration between the two companies. The milestone was triggered as a result of pre-clinical confirmatory studies using the selected lead bispecific antibody candidate that Ono intends to advance into clinical testing. Ono and Merus have also extended their collaboration by signing an additional agreement for CMC activities to be carried out by Merus.

MRUS Merus
$17.91

0.39 (2.23%)

06/13/16
SBSH
06/13/16
INITIATION
Target $14
SBSH
Buy
Merus initiated with a Buy at Citi
Citi analyst Yigal Nochomovitz started Merus with a Buy rating and $14 price target. MCLA-128 can be a $480M drug in metastatic breast cancer if things go well, the analyst tells investors in a research note.
06/13/16
GUGG
06/13/16
INITIATION
Target $18
GUGG
Buy
Merus initiated with a Buy at Guggenheim
Guggenheim analyst Charles Butler started Merus with a Buy rating and $18 price target.
06/13/16
WEDB
06/13/16
INITIATION
Target $14
WEDB
Outperform
Merus initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten started Merus with an Outperform rating and $14 price target. The company offers an opportunity to invest in a "wholly-owned antibody technology platform with two promising and differentiated clinical assets," the analyst tells investors in a research note.
06/13/16
06/13/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Brookfield Renewable (BEP) coverage resumed with an Outperform at BMO Capital. 2. Diamond Offshore (DO) reinstated with a Buy at BofA/Merrill. 3. Merus (MRUS) initiated with a Buy at Citi, a Buy at Guggenheim, and an Outperform at Wedbush. 4. Helmerich & Payne (HP) initiated with a Buy at BofA/Merrill. 5. Dentsply Sirona (XRAY) initiated with an Overweight at Piper Jaffray. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.